HLS Therapeutics Inc - Asset Resilience Ratio

Latest as of September 2023: 10.13%

HLS Therapeutics Inc (HLS) has an Asset Resilience Ratio of 10.13% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read HLS Therapeutics Inc (HLS) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CA$21.81 Million

≈ $15.78 Million USD Cash + Short-term Investments

Total Assets

CA$215.23 Million

≈ $155.69 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2022)

This chart shows how HLS Therapeutics Inc's Asset Resilience Ratio has changed over time. See HLS book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down HLS Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see HLS Therapeutics Inc (HLS) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$21.81 Million	10.13%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$21.81 Million	10.13%

Asset Resilience Insights

Moderate Liquidity: HLS Therapeutics Inc has 10.13% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

HLS Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare HLS Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for HLS Therapeutics Inc (2001–2022)

The table below shows the annual Asset Resilience Ratio data for HLS Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	8.58%	CA$20.72 Million ≈ $14.99 Million	CA$241.65 Million ≈ $174.81 Million	+0.90pp
2021-12-31	7.68%	CA$21.18 Million ≈ $15.32 Million	CA$275.90 Million ≈ $199.59 Million	+0.89pp
2020-12-31	6.78%	CA$20.61 Million ≈ $14.91 Million	CA$303.91 Million ≈ $219.84 Million	-7.94pp
2019-12-31	14.73%	CA$47.08 Million ≈ $34.06 Million	CA$319.67 Million ≈ $231.25 Million	+11.16pp
2018-12-31	3.57%	CA$10.93 Million ≈ $7.91 Million	CA$306.43 Million ≈ $221.66 Million	-5.85pp
2017-12-31	9.42%	CA$36.22 Million ≈ $26.20 Million	CA$384.65 Million ≈ $278.25 Million	+9.05pp
2003-12-31	0.37%	CA$153.46K ≈ $111.01K	CA$41.49 Million ≈ $30.01 Million	-0.24pp
2002-12-31	0.61%	CA$173.60K ≈ $125.58K	CA$28.64 Million ≈ $20.72 Million	+0.04pp
2001-12-31	0.57%	CA$171.84K ≈ $124.31K	CA$30.37 Million ≈ $21.97 Million	--

pp = percentage points

About HLS Therapeutics Inc

TO:HLS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$105.20 Million

CA$145.42 Million CAD

Market Cap Rank

#18986 Global

#637 in Canada

Share Price

CA$4.65

Change (1 day)

+0.00%

52-Week Range

CA$4.27 - CA$5.72

All Time High

CA$24.20